Showing results (51-60 of 270) with videos related to

Sort By:
Pageof 27
British Journal of Clinical Pharmacology|June 1, 1983
Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in manJ Vincent, H L Elliott, P A Meredith, et al.
Journal of Cardiovascular Pharmacology|January 1, 1985
Clinical pharmacological studies on the interaction between alpha-adrenoceptors and calcium antagonistsJ L Reid, F Pasanisi, P A Meredith, et al.
Journal of Cardiovascular Pharmacology|December 1, 1987
An evaluation of the pharmacodynamics and pharmacokinetics of nicardipine combined with enalapril in essential hypertensionR Donnelly, H L Elliott, P A Meredith, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Clinical pharmacological studies with the vasodilator endralazine in patients with renal impairmentH L Elliott, P A Meredith, L Sloan, et al.
Journal of Pharmacological Methods|December 1, 1981
The determination of labetalol in plasma by high-performance liquid chromatography using fluorescence detectionP A Meredith, D McSharry, H L Elliott, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
Pressor responsiveness in essential hypertension and the effects of treatment with an alpha blocker, calcium antagonist or ACE inhibitorJ L Reid, R Donnelly, P A Meredith, et al.
British Journal of Clinical Pharmacology|January 1, 1986
Clinical pharmacological studies with doxazosinH L Elliott, P A Meredith, J Vincent, et al.
Clinical Pharmacology and Therapeutics|May 1, 1988
The combination of prazosin and verapamil in the treatment of essential hypertensionH L Elliott, P A Meredith, L Campbell, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1988
Kinetic-dynamic relationships and antihypertensive mechanisms of ketanserin in essential hypertensionR Donnelly, H L Elliott, P A Meredith, et al.
Pageof 27